Mapping molecular neighborhoods
Associate Professor Ernest Fraenkel uses biological network modeling to identify new targets for disease.
New microfluidic device offers means for studying electric field cancer therapy
Low-intensity fields keep malignant cells from spreading, while preserving healthy cells.
Engineers design programmable RNA vaccines
Tests in mice show the vaccines work against Ebola, influenza, and a common parasite.
A strategy for “convergence” research to transform biomedicine
Report calls for more integration of physical, life sciences for needed advances in biomedical research.
Gene circuits in live cells can perform complex computations
Technique combines analogue and digital processes in engineered cells.
Lung cancer “breathalyzer” wins $100K Entrepreneurship Competition
Team’s smartphone-connected device can detect lung cancer early from a single breath.
New approach to genetic analysis yields markers linked to complex diseases
Study identifies new gene variants that may be targets for treating arrhythmia.
Method for earlier detection of leukemia wins $300,000 grant
Team takes home grand prize from Koch Institute’s unique research-grant pitch competition.
New study shows rich, poor have huge mortality gap in U.S.
In unprecedented detail, lifespan gap shown to be large and growing rapidly.
Taking on melanoma, one cell at a time
In step toward personalized medicine, researchers are using single-cell analysis to unravel cancer’s secrets.
Reprogramming gut bacteria as “living therapeutics”
Daily doses of synthetic biotics developed by startup Synologic may sense, treat metabolic diseases.
Sepsis-curing device wins new health care prize
Device that filters blood to prevent organ failure wins MIT Sloan Healthcare Innovations Prize.
Confronting Zika
MIT's Institute of Medical Engineering and Science is on the front lines of efforts to diagnose and develop a vaccine against the emerging Zika virus.